Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Women on GLP-1 drugs had an 8% lower risk of obesity-related cancers and a 20% lower risk of death from any cause, compared to those taking #DPP4 inhibitors
By combining GLP-1 receptor agonists with other agents, such as GIP or glucagon receptor agonists, researchers are achieving greater weight loss, improved glycemic control, and broader metabolic benefits
On average, the drugs cost $1,540 per prescription, but patients paid an average of just under $35 out-of-pocket for each prescription
L.MaternD.TamaiI.et al (2004)
US$ 21.87
US$ 27.10
US$ 20.94
US$ 28.26
US$ 21.12
